{"downloaded": true, "htmlmade": false, "full": {"id": "29431027", "source": "MED", "pmid": "29431027", "pmcid": "PMC6142101", "fullTextIdList": {"fullTextId": "PMC6142101"}, "doi": "10.1177/1534735418756736", "title": "A Controlled Trial of Sheng-Yu-Tang for Post-Hematopoietic Stem Cell Transplantation Leukemia Patients: A Proposed Protocol and Insights From a Preliminary Pilot Study.", "authorString": "Fleischer T, Chang TT, Chiang JH, Yen HR.", "authorList": {"author": [{"fullName": "Fleischer T", "firstName": "Tom", "lastName": "Fleischer", "initials": "T", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "1 China Medical University, Taichung, Taiwan."}}}, {"fullName": "Chang TT", "firstName": "Tung-Ti", "lastName": "Chang", "initials": "TT", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "1 China Medical University, Taichung, Taiwan."}, {"affiliation": "2 China Medical University Hospital, Taichung, Taiwan."}]}}, {"fullName": "Chiang JH", "firstName": "Jen-Huai", "lastName": "Chiang", "initials": "JH", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "1 China Medical University, Taichung, Taiwan."}, {"affiliation": "2 China Medical University Hospital, Taichung, Taiwan."}]}}, {"fullName": "Yen HR", "firstName": "Hung-Rong", "lastName": "Yen", "initials": "HR", "authorId": {"@type": "ORCID", "#text": "0000-0002-0131-1658"}, "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "1 China Medical University, Taichung, Taiwan."}, {"affiliation": "2 China Medical University Hospital, Taichung, Taiwan."}, {"affiliation": "3 Asia University, Taichung, Taiwan."}]}}]}, "authorIdList": {"authorId": {"@type": "ORCID", "#text": "0000-0002-0131-1658"}}, "dataLinksTagsList": {"dataLinkstag": ["supporting_data", "altmetrics"]}, "journalInfo": {"issue": "3", "volume": "17", "journalIssueId": "2717315", "dateOfPublication": "2018 Sep", "monthOfPublication": "9", "yearOfPublication": "2018", "printPublicationDate": "2018-09-01", "journal": {"title": "Integrative cancer therapies", "ISOAbbreviation": "Integr Cancer Ther", "medlineAbbreviation": "Integr Cancer Ther", "NLMid": "101128834", "ISSN": "1534-7354", "ESSN": "1552-695X"}}, "pubYear": "2018", "pageInfo": "665-673", "abstractText": "INTRODUCTION:Hematopoietic stem cell transplantation has become a well-established treatment for hematologic disorders including acute leukemia. However, long-term survival rates following this procedure are still extremely low, due to posttransplantation relapse, infections, and graft-versus-host disease. We propose that adjunctive Chinese herbal medicine may benefit posttransplantation patients. In preparation for a randomized clinical trial, we conducted a pilot trial. Methods and Analysis: Between September 2015 and June 2017, 18 patients were consecutively enrolled at China Medical University Hospital and followed for up to 1 year. Fresh blood samples were obtained on a monthly basis, and immune reconstitution was analyzed. In addition to the standard-care treatment administered by their oncologist, a number of patients also received a Chinese herbal formula (Sheng-Yu-Tang) for up to 6 months. Results were used to improve on study protocol and estimate required sample size for a future randomized trial. Ethics and Dissemination: Study protocol was approved by the institutional review board of China Medical University Hospital (DMR-105-005), and all participants provided informed consent.", "affiliation": "1 China Medical University, Taichung, Taiwan.", "publicationStatus": "ppublish", "language": "eng", "pubModel": "Print-Electronic", "pubTypeList": {"pubType": ["Clinical Trial", "Research Support, Non-U.S. Gov't", "research-article", "Randomized Controlled Trial", "Journal Article"]}, "meshHeadingList": {"meshHeading": [{"majorTopic_YN": "N", "descriptorName": "Humans"}, {"majorTopic_YN": "N", "descriptorName": "Leukemia", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DT", "qualifierName": "drug therapy", "majorTopic_YN": "Y"}, {"abbreviation": "TH", "qualifierName": "therapy", "majorTopic_YN": "Y"}]}}, {"majorTopic_YN": "N", "descriptorName": "Drugs, Chinese Herbal", "meshQualifierList": {"meshQualifier": {"abbreviation": "TU", "qualifierName": "therapeutic use", "majorTopic_YN": "Y"}}}, {"majorTopic_YN": "N", "descriptorName": "Hematopoietic Stem Cell Transplantation", "meshQualifierList": {"meshQualifier": {"abbreviation": "MT", "qualifierName": "methods", "majorTopic_YN": "N"}}}, {"majorTopic_YN": "N", "descriptorName": "Pilot Projects"}, {"majorTopic_YN": "N", "descriptorName": "Adult"}, {"majorTopic_YN": "N", "descriptorName": "Aged"}, {"majorTopic_YN": "N", "descriptorName": "Middle Aged"}, {"majorTopic_YN": "N", "descriptorName": "Female"}, {"majorTopic_YN": "N", "descriptorName": "Male"}]}, "keywordList": {"keyword": ["Chinese herbal medicine", "Acute leukemia", "Immune reconstitution", "HSCT"]}, "chemicalList": {"chemical": {"name": "Drugs, Chinese Herbal", "registryNumber": "0"}}, "subsetList": {"subset": {"code": "IM", "name": "Index Medicus"}}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.1177/1534735418756736"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6142101"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6142101?pdf=render"}]}, "isOpenAccess": "Y", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "N", "citedByCount": "1", "hasData": "Y", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "license": "cc by-nc", "authMan": "N", "epmcAuthMan": "N", "nihAuthMan": "N", "hasTMAccessionNumbers": "Y", "tmAccessionTypeList": {"accessionType": "nct"}, "dateOfCompletion": "2019-03-28", "dateOfCreation": "2018-02-13", "firstIndexDate": "2018-02-12", "fullTextReceivedDate": "2020-07-09", "dateOfRevision": "2019-03-28", "electronicPublicationDate": "2018-02-11", "firstPublicationDate": "2018-02-11"}, "htmllinks": "https://europepmc.org/articles/PMC6142101", "abstract": "INTRODUCTION:Hematopoietic stem cell transplantation has become a well-established treatment for hematologic disorders including acute leukemia. However, long-term survival rates following this procedure are still extremely low, due to posttransplantation relapse, infections, and graft-versus-host disease. We propose that adjunctive Chinese herbal medicine may benefit posttransplantation patients. In preparation for a randomized clinical trial, we conducted a pilot trial. Methods and Analysis: Between September 2015 and June 2017, 18 patients were consecutively enrolled at China Medical University Hospital and followed for up to 1 year. Fresh blood samples were obtained on a monthly basis, and immune reconstitution was analyzed. In addition to the standard-care treatment administered by their oncologist, a number of patients also received a Chinese herbal formula (Sheng-Yu-Tang) for up to 6 months. Results were used to improve on study protocol and estimate required sample size for a future randomized trial. Ethics and Dissemination: Study protocol was approved by the institutional review board of China Medical University Hospital (DMR-105-005), and all participants provided informed consent.", "Keywords": ["Chinese herbal medicine", "Acute leukemia", "Immune reconstitution", "HSCT"], "pdflinks": "https://europepmc.org/articles/PMC6142101?pdf=render", "journaltitle": "Integrative cancer therapies", "authorinfo": ["Fleischer T", "Chang TT", "Chiang JH", "Yen HR"], "title": "A Controlled Trial of Sheng-Yu-Tang for Post-Hematopoietic Stem Cell Transplantation Leukemia Patients: A Proposed Protocol and Insights From a Preliminary Pilot Study."}